Literature DB >> 12592317

26. Immunomodulation and immunotherapy: drugs, cytokines, cytokine receptors, and antibodies.

Robert P Nelson1, Mark Ballow.   

Abstract

The preceding chapters in this primer have provided an overview of the immune response that serves as a background for understanding potential sites for immune modulation and immunotherapy. A number of soluble growth and activation factors are released from various cell populations involved in the immune response. They play vital roles in the initiation, propagation, and regulation of immunologic responses. Pharmacologic immunomodulators include suppressive and stimulatory agents. Immunosuppressive therapies include antimetabolites, cytotoxic drugs, radiation, adrenocortical glucocorticosteroids, immunophilins, and therapeutic antibodies. The field of clinical immunostimulation is emerging as an important therapeutic modality for a number of immunodeficiency diseases, chronic viral infections, and cancer. These compounds will be discussed in terms of general principles, molecular targets, major indications, and adverse effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12592317     DOI: 10.1067/mai.2003.146

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  13 in total

1.  Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies.

Authors:  Tarek Taha; David Meiri; Samira Talhamy; Mira Wollner; Avivit Peer; Gil Bar-Sela
Journal:  Oncologist       Date:  2019-01-22

2.  Engineering drug delivery systems to overcome mucosal barriers for immunotherapy and vaccination.

Authors:  Jacob C McCright; Katharina Maisel
Journal:  Tissue Barriers       Date:  2019-11-28

3.  Home care use of intravenous and subcutaneous immunoglobulin for primary immunodeficiency in the United States.

Authors:  Faith Huang; Elizabeth Feuille; Charlotte Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2012-09-08       Impact factor: 8.317

4.  Signal recognition particle (SRP) positive myositis in a patient with cryptogenic organizing pneumonia (COP).

Authors:  Felix Wantke; Meinhard Kneussl; Marianne Hubner; Kurt Derfler; Thomas Brücke; Sabine Schmaldienst
Journal:  Rheumatol Int       Date:  2009-07-29       Impact factor: 2.631

5.  Reactivity of the immunological system of rats stimulated with Biolex-Beta HP after cyclophosphamide immunosuppression.

Authors:  Roman Wójcik
Journal:  Cent Eur J Immunol       Date:  2014-04-17       Impact factor: 2.085

6.  The effects of orally administered Beta-glucan on innate immune responses in humans, a randomized open-label intervention pilot-study.

Authors:  Jenneke Leentjens; Jessica Quintin; Jelle Gerretsen; Matthijs Kox; Peter Pickkers; Mihai G Netea
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

7.  EFFECTS OF COMBRETUM HEREROENSE AND CANTHIUMMUNDIANUM water EXTRACTS ON PRODUCTION AND EXPRESSION OF INTERLEUKIN-4.

Authors:  Amidou Samie; Nditsheni Madzie
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-11-23

Review 8.  Botanical immunodrugs: scope and opportunities.

Authors:  Bhushan Patwardhan; Manish Gautam
Journal:  Drug Discov Today       Date:  2005-04-01       Impact factor: 7.851

Review 9.  Therapeutic and Prophylactic Use of Oral, Low-Dose IFNs in Species of Veterinary Interest: Back to the Future.

Authors:  Sara Frazzini; Federica Riva; Massimo Amadori
Journal:  Vet Sci       Date:  2021-06-11

10.  Prevention of Prostate Tumor Development by Stimulation of Antitumor Immunity Using a Standardized Herbal Extract (Deep Immune®) in TRAMP Mice.

Authors:  Peihe Liang; Jia Guo; Shadan Li; Qiunong Guan; Terry Vanderheyden; Alan So; Yuzhuo Wang; Tao Chen; Caigan Du
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-14       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.